PolyActive^® is a biodegradable polymeric drug delivery system

Its biodegradability, extensive safety record and linear release properties make PolyActive^® an excellent technology for the controlled release of proteins and lipophilic small molecules.

Products based on PolyActive^® can be used for both local and systemic administration, and have applications in pharmaceutics and medical technology.

Key attributes of the PolyActive^® drug delivery system are:

• Suitable to encapsulate both small- and macromolecules
• Controllable, including linear, release profiles
• Low initial release: no burst
• Strong in vitro - in vivo correlation
• Well-preserved compound stability and activity
• Biodegradable and biocompatible
• Systemic and local applications
• Extensive biological safety file
• FDA approval and CE mark for medical devices
• Patent protected

Partner with OctoPlus for drug delivery with PolyActive^®
OctoPlus is actively pursuing new partnerships to develop products based on the PolyActive^® delivery system. As a medium sized organisation, we are flexible in constructing partnership agreements and are open to take on some of the risk and cost for the development of promising compounds. Our priority is to build successful long-term drug delivery partnerships. Please feel free to contact us and discuss your ideas.

OctoPlus' hepatitis C product Locteron^® is based on PolyActive^® technology.

For more information on OctoPlus' PolyActive^® drug delivery technology, please download our PolyActive^® factsheet.